epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

J Allergy Clin Immunol

New consensus clarifies when to administer epinephrine and call EMS during allergic reactions

February 19, 2026

card-image

An international panel of 34 anaphylaxis experts has released the first consensus-based recommendations to guide epinephrine use and emergency medical services (EMS) activation in community settings, addressing years of conflicting advice in existing action plans. The report outlines scenario‑based guidance developed through a modified Delphi process, covering a wide spectrum of reaction severities and clinical modifiers. The panel reached consensus to recommend epinephrine for most scenarios involving respiratory, cardiovascular/neurologic, severe GI, or multi‑system symptoms, while discouraging its use for isolated mild skin or mild GI symptoms. Historical “modifiers,” such as prior need for multiple epinephrine doses or history of mast cell disorders, were identified as important factors that may lower the threshold for administration. The guidance also introduces clearer recommendations on when EMS activation is necessary, aiming to reduce unnecessary emergency department utilization while ensuring timely care for high‑risk reactions.

Clinical takeaway: When evaluating an acute allergic reaction, prioritize epinephrine for any respiratory, cardiovascular/neurologic, severe GI, or multisystem symptoms, and use patient history to guide decisions in borderline cases.

Source:

Dribin TE, et al. (2026, February 15). J Allergy Clin Immunol. Epinephrine and emergency medical services activation recommendations during acute allergic reactions in community settings: International consensus report. https://pubmed.ncbi.nlm.nih.gov/41386477/

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information